Showing results (361-370 of 2,902) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|July 5, 2008
E. coli nitroreductase/CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2D J Mitchell, R F MinchinCancer Gene Therapy|July 5, 2008
Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTDJ-I Youn, S-H Park, H-T Jin, et al.Cancer Gene Therapy|July 26, 2008
Chimeric form of tumor necrosis factor-alpha has enhanced surface expression and antitumor activityR Rieger, D Whitacre, M J Cantwell, et al.Cancer Gene Therapy|July 26, 2008
Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50 kb DNA fragmentationJ Zhou, X-Q Zhang, F Ashoori, et al.Cancer Gene Therapy|July 26, 2008
Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer modelM-A Shibata, J Morimoto, E Shibata, et al.Cancer Gene Therapy|June 27, 2006
The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancerL Zhao, A Dong, J Gu, et al.Cancer Gene Therapy|July 1, 2006
Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenesW Gu, L Putral, K Hengst, et al.Cancer Gene Therapy|May 5, 2007
Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapyZ R Yang, H F Wang, J Zhao, et al.Cancer Gene Therapy|May 5, 2007
An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cellsC Y-F Lee, L X Bu, P S Rennie, et al.Cancer Gene Therapy|May 26, 2007
Calcium depletion enhances nectin-1 expression and herpes oncolytic therapy of squamous cell carcinomaZ Yu, S Li, Y-Y Huang, et al.Pageof 291